Literature DB >> 12452204

Risk factors for recurrent asthma hospital visits and death among a population of indigent older adults with asthma.

Tina V Hartert1, Theodore Speroff, Alkis Togias, Edward F Mitchel, Mary S Snowden, Robert S Dittus, Marie R Griffin.   

Abstract

BACKGROUND: Little is known about the morbidity and mortality among older adults with asthma requiring hospital care.
OBJECTIVES: To determine whether an initial hospital visit for asthma was associated with an increase in use of inhaled corticosteroids (CCS) at discharge, and to identify risk factors for recurrent asthma hospital visits and death.
METHODS: A retrospective cohort analysis identified 93,174 persons 65 years and older enrolled in the Tennessee Medicaid program for at least 1 year and free of asthma hospital visits during that year; 510 survived a single hospital visit for asthma in 1992 and comprised the study population. Main outcome measures included recurrent hospital visit for asthma and all-cause mortality during the year after an asthma hospital visit.
RESULTS: Among the 510 study subjects, 10% were on inhaled CCS at admission compared with 11% at discharge. Twenty-three percent of the population had recurrent asthma hospital visits and 12% died during 1-year followup. Asthma severity was the strongest independent risk factor for both a recurrent hospital visit [relative risk for moderate to severe disease 1.92 (1.01 to 3.66), and for near-fatal disease 2.28 (1.01 to 5.13), respectively] and death [relative risk for moderate to severe disease 2.99 (1.07 to 8.32) and for near-fatal disease 4.44 (1.34 to 4.69), respectively].
CONCLUSIONS: In this population, older adults with an exacerbation of asthma requiring hospital care experienced significant morbidity and mortality. An acute hospital visit for an asthma exacerbation did not result in initiation of inhaled CCS therapy. Asthma severity predicted both recurrent hospital visits and all-cause mortality among older adults with asthma requiring hospital care.

Entities:  

Mesh:

Year:  2002        PMID: 12452204     DOI: 10.1016/S1081-1206(10)62083-2

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  14 in total

Review 1.  Age-related changes in immune function: effect on airway inflammation.

Authors:  Paula J Busse; Sameer K Mathur
Journal:  J Allergy Clin Immunol       Date:  2010-10       Impact factor: 10.793

Review 2.  Treating asthma in the older patient: is there a place for leukotriene modifiers?

Authors:  Mitchell H Grayson; Phillip E Korenblat
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

3.  Dose, Timing, and Type of Infant Antibiotic Use and the Risk of Childhood Asthma.

Authors:  Brittney M Donovan; Andrew Abreo; Tan Ding; Tebeb Gebretsadik; Kedir N Turi; Chang Yu; Juan Ding; William D Dupont; Cosby A Stone; Tina V Hartert; Pingsheng Wu
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

Review 4.  The role of omalizumab in the treatment of severe allergic asthma.

Authors:  Kenneth R Chapman; Andre Cartier; Jacques Hébert; R Andrew McIvor; R Robert Schellenberg
Journal:  Can Respir J       Date:  2006 Jul-Aug       Impact factor: 2.409

5.  Targeting integrin α5β1 ameliorates severe airway hyperresponsiveness in experimental asthma.

Authors:  Aparna Sundaram; Chun Chen; Amin Khalifeh-Soltani; Amha Atakilit; Xin Ren; Wenli Qiu; Hyunil Jo; William DeGrado; Xiaozhu Huang; Dean Sheppard
Journal:  J Clin Invest       Date:  2016-12-05       Impact factor: 14.808

6.  Effect of aging on sputum inflammation and asthma control.

Authors:  Paula J Busse; Janette M Birmingham; Agustin Calatroni; Joseph Manzi; Anna Goryachokovsky; Giselle Fontela; Alex D Federman; Juan P Wisnivesky
Journal:  J Allergy Clin Immunol       Date:  2016-10-08       Impact factor: 10.793

7.  Diabetes and asthma case identification, validation, and representativeness when using electronic health data to construct registries for comparative effectiveness and epidemiologic research.

Authors:  Jay R Desai; Pingsheng Wu; Greg A Nichols; Tracy A Lieu; Patrick J O'Connor
Journal:  Med Care       Date:  2012-07       Impact factor: 2.983

8.  The developmental trajectory of pediatric asthma in 3- to-10-year-olds.

Authors:  Pingsheng Wu; Kecia N Carroll; Tebeb Gebretsadik; William D Dupont; Edward F Mitchel; Tina V Hartert
Journal:  J Allergy Clin Immunol       Date:  2012-02-08       Impact factor: 10.793

9.  Asthma and pulmonary function abnormalities in heterozygotes for cystic fibrosis transmembrane regulator gene mutations.

Authors:  Konstantinos Douros; Ioanna Loukou; Stavros Doudounakis; Maria Tzetis; Kostas N Priftis; Emmanuel Kanavakis
Journal:  Int J Clin Exp Med       Date:  2008-10-27

Review 10.  Complexities of diagnosis and treatment of allergic respiratory disease in the elderly.

Authors:  Paula J Busse; Kiran Kilaru
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.